394420 — RecensMedical Income Statement
0.000.00%
Last trade - 00:00- KR₩347bn
- KR₩347bn
- KR₩9bn
Annual income statement for RecensMedical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 282 | 5,771 | 6,259 | 8,829 |
| Cost of Revenue | ||||
| Gross Profit | 113 | 3,038 | 1,374 | 4,331 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Depreciation and Amortization | ||||
| Total Operating Expenses | 20,527 | 18,354 | 20,420 | 19,469 |
| Operating Profit | -20,245 | -12,584 | -14,161 | -10,640 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -40,994 | -7,572 | -7,844 | -19,119 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -40,994 | -7,572 | -7,844 | -19,119 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -40,994 | -7,572 | -7,844 | -19,119 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -40,994 | -7,572 | -7,844 | -19,119 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -3,778 | -692 | -723 | -1,781 |
| Dividends per Share |